Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Howard

Showing results (301-310 of 429) with videos related to

Pageof 43
Sort By:
Transactions of the Royal Society of Tropical Medicine and Hygiene|August 7, 2015
Diagnostic accuracy of rK28-based immunochromatographic rapid diagnostic tests for visceral leishmaniasis: a prospective clinical cohort study in SudanMaowia Mukhtar, Asim Abdoun, Abdallah E Ahmed, et al.
Vaccine|May 12, 2009
Leishmania infantum sterol 24-c-methyltransferase formulated with MPL-SE induces cross-protection against L. major infectionYasuyuki Goto, Ajay Bhatia, Vanitha S Raman, et al.
Vaccine|September 30, 2009
Optimized subunit vaccine protects against experimental leishmaniasisSylvie Bertholet, Yasuyuki Goto, Lauren Carter, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 21, 2000
Gynaecological and obstetrical morbidity in women with type I von Willebrand disease: results of a patient surveyP A Kouides, P D Phatak, P Burkart, et al.
NEJM Evidence|February 6, 2024
Terminal Complement Inhibitor Ravulizumab in Generalized Myasthenia GravisTuan Vu, Andreas Meisel, Renato Mantegazza, et al.
Neurology and Therapy|June 23, 2023
Summary of Research: Terminal Complement Inhibitor Ravulizumab in Generalized Myasthenia GravisTuan Vu, Andreas Meisel, Renato Mantegazza, et al.
Vaccine|May 1, 2012
Intradermally administered TLR4 agonist GLA-SE enhances the capacity of human skin DCs to activate T cells and promotes emigration of Langerhans cellsLaura P Schneider, Antoinet J Schoonderwoerd, Magdalini Moutaftsi, et al.
Journal of Clinical Microbiology|October 21, 2025
Self-collection for primary HPV screening using dry swabs: a review of clinical performance, laboratory considerations, and patient preferencesMondraya F Howard, Ria C Fyffe-Freil, Christina C Pierre, et al.
Muscle & Nerve|June 23, 2025
Pain Experiences and Prescription Pain Medications Among People With Selected Muscular Dystrophies in the Muscular Dystrophy Surveillance, Tracking, and Research NetworkJonathan Suhl, Kristin M Conway, Shiny Thomas, et al.
Journal of Neuroimmunology|October 15, 2018
Circulating microRNA plasma profile in MuSK+ myasthenia gravisLiis Sabre, Jeffrey T Guptill, Melissa Russo, et al.
Pageof 43

Showing results (301-310 of 429) with videos related to

Sort By:
Pageof 43
Transactions of the Royal Society of Tropical Medicine and Hygiene|August 7, 2015
Diagnostic accuracy of rK28-based immunochromatographic rapid diagnostic tests for visceral leishmaniasis: a prospective clinical cohort study in SudanMaowia Mukhtar, Asim Abdoun, Abdallah E Ahmed, et al.
Vaccine|May 12, 2009
Leishmania infantum sterol 24-c-methyltransferase formulated with MPL-SE induces cross-protection against L. major infectionYasuyuki Goto, Ajay Bhatia, Vanitha S Raman, et al.
Vaccine|September 30, 2009
Optimized subunit vaccine protects against experimental leishmaniasisSylvie Bertholet, Yasuyuki Goto, Lauren Carter, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 21, 2000
Gynaecological and obstetrical morbidity in women with type I von Willebrand disease: results of a patient surveyP A Kouides, P D Phatak, P Burkart, et al.
NEJM Evidence|February 6, 2024
Terminal Complement Inhibitor Ravulizumab in Generalized Myasthenia GravisTuan Vu, Andreas Meisel, Renato Mantegazza, et al.
Neurology and Therapy|June 23, 2023
Summary of Research: Terminal Complement Inhibitor Ravulizumab in Generalized Myasthenia GravisTuan Vu, Andreas Meisel, Renato Mantegazza, et al.
Vaccine|May 1, 2012
Intradermally administered TLR4 agonist GLA-SE enhances the capacity of human skin DCs to activate T cells and promotes emigration of Langerhans cellsLaura P Schneider, Antoinet J Schoonderwoerd, Magdalini Moutaftsi, et al.
Journal of Clinical Microbiology|October 21, 2025
Self-collection for primary HPV screening using dry swabs: a review of clinical performance, laboratory considerations, and patient preferencesMondraya F Howard, Ria C Fyffe-Freil, Christina C Pierre, et al.
Muscle & Nerve|June 23, 2025
Pain Experiences and Prescription Pain Medications Among People With Selected Muscular Dystrophies in the Muscular Dystrophy Surveillance, Tracking, and Research NetworkJonathan Suhl, Kristin M Conway, Shiny Thomas, et al.
Journal of Neuroimmunology|October 15, 2018
Circulating microRNA plasma profile in MuSK+ myasthenia gravisLiis Sabre, Jeffrey T Guptill, Melissa Russo, et al.
Pageof 43